Drug intelligence / Profile preview

Torcytech-S

Development stage
Unknown
Lead developer
Cytech Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Torcytech-S is a fixed-dose combination oral medication developed and marketed by Cytech Pharma in India. It contains 10 mg of torasemide and 50 mg of spironolactone. Torasemide is a loop diuretic that inhibits the Na+-K+-2Cl- cotransporter (NKCC2) in the thick ascending limb of the loop of Henle, leading to significant excretion of water and electrolytes. Spironolactone is a potassium-sparing diuretic that acts as a competitive antagonist of the mineralocorticoid receptor (aldosterone receptor), primarily in the distal renal tubules. By combining these two agents, Torcytech-S effectively manages edema and fluid retention associated with congestive heart failure, liver cirrhosis with ascites, and nephrotic syndrome, while helping to maintain potassium balance. It is particularly indicated when a potassium-sparing adjunct is necessary to prevent hypokalemia induced by loop diuretics.

Brand names
Torcytech-S
Other names
torasemide + spironolactoneTorasemide 10 mg + Spironolactone 50 mg
02

Targets

MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on Torcytech-S.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Torcytech-S.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call